Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinib (Q39320168)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinib |
scientific article |
Statements
1 reference
Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinib (English)
1 reference
Ondrej Kalous
1 reference
Dylan Conklin
1 reference
Amrita J Desai
1 reference
Neil A O'Brien
1 reference
Charles Ginther
1 reference
Lee Anderson
1 reference
David J Cohen
1 reference
Carolyn D Britten
1 reference
Ian Taylor
1 reference
James G Christensen
1 reference
Dennis J Slamon
1 reference
Richard S Finn
1 reference
3 July 2012
1 reference
1 reference
1978-1987
1 reference
Identifiers
1 reference